In the recent decades, there has been considerable interest in using Carbopolas an excipient in a diverse range of pharmaceutical applications.Carbopol polymers are polymers of acrylic acid cross-linked with polyalkenyl ethers or divinyl glycol. They are produced from primary polymer particles of about 0.2 to 6.0 micron average diameter. The flocculated agglomerates cannot be broken into the ultimate particles when produced. Each particle can be viewed as a network structure of polymer chains interconnected via cross-linking1.Carbomers were first prepared and patented in 19572. Since then, a number of extended release tablet formulations, which involve carbomer matrices, have been patented3.Carbomers readily absorb water, get hydrated and swell. In addition to its hydrophilic nature, its cross-linked structure and its essentially insolubility in water makes Carbopol a potential candidate for use in controlled release drug delivery system.4,5